NEMIC Welcomes Veranex as Corporate Sponsor

PROVIDENCE, RI — Veranex–a global, end-to-end service provider for medical device companies–this month became the latest esteemed institution to join NEMIC’s growing corporate membership program. 

“By building-out our membership base to include a broad and diverse representation of the various sectors within HealthTech, we continue to bolster Rhode Island’s ever-growing Life Science ecosystem,"  said Andrew Williamson, Business & Engagement Coordinator at NEMIC.

NEMIC launched its Corporate Membership program in 2023 with the vision of bolstering the entrepreneurial and life sciences ecosystems in Rhode Island by procuring a suite of member corporations that support innovation.  

Veranex joins the ranks which include Nova design and AlvaMed device consulting firm.  

With local offices right here in Providence, Veranex also boasts an impressive 23 additional locations dotted across the globe, from Europe, to Australia, to China, India and beyond. Having such a corporate member in NEMIC’s cohort of existing members provides critical industry knowledge and scope to Rhode Island’s aspirations of developing into a bonafide hub in Health Technology.  By connecting corporations to Southern New England's thriving Life Sciences ecosystem, NEMIC will be able to fold-in various private sector corporations to support innovators with critical resources they need in order to succeed.

As NEMIC continues delivering on driving innovation in that space through a robust pipeline of fundable companies, a full complement of corporate members allows NEMIC-guided companies to have access to an impressive array of subject matter experts, industry connections, and more.  

ABOUT VERANEX

Veranex is a multinational corporation in the medical device space with a mission to deliver efficient, interdisciplinary services to healthcare partners, propelled by the best-in-class experience of their people.  They have a vision to be experts who empower experts, working alongside healthcare partners on their journey to advance medical care and improve patient lives.  From concept to commercialization, Veranex provides vast insight in areas such as accelerated speed to market, controlled development costs, development risk mitigation, market viability assessment, and more in order to help MedTech companies maximize efficiency in cost and time through integrated, comprehensive solutions.